PpWe are looking for a driven and highly motivated Business Development Director, Oncology to join our Oncology Business Development Licensing team. /p pThis role is designed for an ambitious BD professional with oncology deal-making experience who is ready to take the next step in their career. Reporting to a senior BD leader, the successful candidate will support oncology BDL activities, contribute to deal processes, and help advance business opportunities across new and existing portfolio assets. /p pThis is a hands-on role for someone who is curious, commercially minded, scientifically engaged, and eager to grow within a global oncology organization. /p h3Key Responsibilities /h3 ul liSupport oncology BDL activities focused on identifying and advancing new business opportunities. /li liSupport deal-making processes for preclinical and clinical-stage oncology assets. /li liLead activities related to lifecycle management of the existing oncology portfolio. /li liHelp coordinate cross-functional activities to enable efficient and well-aligned deal processes. /li liBuild and maintain effective relationships with internal stakeholders and external partners. /li liWork closely with senior BD leadership to support project planning, execution, and follow-through. /li liEnsure activities are conducted in line with company standards, governance processes, and compliance requirements. /li /ul h3Required Experience and Qualifications /h3 ul liDegree in life sciences or equivalent; a degree in law or economics may also be relevant. /li liMBA from a leading business school is a strong advantage. /li li5+ years of experience in oncology business development, with hands‑on experience supporting collaborations and in‑/out‑licensing activities. /li liGood understanding of the oncology pharma/biotech environment, including deal‑making trends and the oncology landscape. /li /ul h3Skills and Capabilities /h3 ul liAbility to understand oncology science and translate it into business relevance. /li liBusiness acumen and ability to work with key business case assumptions and top‑line KPIs. /li liAbility to manage requests from senior internal stakeholders and support high‑quality contracting alignment across cross‑functional teams. /li liStrong analytical skills, with a proven ability to generate meaningful business insights and precise deal benchmarking. /li liAgile team player with the capability to drive multiple parallel projects from planning through execution with increasing autonomy, while taking ownership of project workstreams. /li liExcellent communication and presentation skills. /li liFlexible, versatile, collaborative, and comfortable working across multiple functions and geographies. /li liStrong team orientation, with the ability to support projects from planning through execution. /li liWillingness to travel internationally as needed, approximately 15%. /li /ul h3The Menarini Group: Innovation, Ethics, and Global Impact /h3 pFounded in 1886 and headquartered in Florence, Italy, the Menarini Group is a leading international pharmaceutical company dedicated to providing high‑quality therapeutics and advanced diagnostics for patients globally. /p pOur foundation is built upon four key pillars: People Care, Patient Focus, Quality, Responsibility Integrity /p h3Key Facts /h3 ul liGlobal Reach: Present in 70 countries, with products sold in 140 locations worldwide. /li liTeam: Around 18,000 employees globally. /li liManufacturing: 18 manufacturing sites across 6 continents, producing over 500 million packs of drugs annually. /li /ul h3Our Focus on Oncology /h3 pMenarini has made a strong, strategic commitment to Oncology, combining innovative therapeutic solutions with advanced liquid biopsy‑based diagnostics to drive faster, more effective, and precise patient management. /p pOur oncology portfolio has been significantly strengthened through the acquisition of Stemline Therapeutics and key licensing agreements, marking our entry into the U.S. oncology market and expanding our presence in Europe and beyond. /p pKey examples of our cutting‑edge work include: /p ul liTargeted Therapies: Developing first‑in‑class targeted therapies for rare hematological cancers, including a treatment for blastic plasmacytoid dendritic cell neoplasm (BPDCN), and licensed oral agents for hematologic cancers and solid tumors, such as a first‑in‑class Selective Inhibitor of Nuclear export compound (for which we hold commercialization rights in Europe). /li liEndocrine Therapies: Advancing late‑stage oral therapies, like a Selective Estrogen Receptor Degrader (SERD), for the treatment of hormone receptor‑positive advanced breast cancer. /li liAdvanced Diagnostics: Our affiliate, Menarini Silicon Biosystems (MSB), is a pioneer in rare cell analysis and non‑invasive diagnostics. Their Circulating Tumour Cell (CTC) Test is the only FDA‑cleared blood test for detecting and counting CTCs in certain metastatic cancers. /li /ul pThis is an exciting time of growth and development for the company. We invite talented individuals to join us in shaping and building the future of the Menarini Stemline Oncology business. /p /p #J-18808-Ljbffr